Appeal No. 2006-3290 Page 6 Application No. 10/072,823 Appellant asserts that ‘016, ‘434, Son or Ito do not teach the type of cancer that can be treated with the compound or extract. Brief, pages 5-6.5 However, as discussed above, there is no requirement in Appellant’s claim 1 that cancer generally or any particular type of cancer be treated. As set forth in In re Pearson, 494 F.2d 1399, 1403, 181 USPQ 641, 644 (CCPA 1974), “terms [that] merely set forth the intended use for ... an otherwise old composition ... do not differentiate the claimed composition from those known in the prior art.” The Pearson court explained that “[i]t seems quite clear to us that one of the compositions admitted to be old by the appellant would not undergo a metamorphosis to a new composition by labeling its container to show that it is a composition suitable for [another use].” Id. The evidence of record establishes that both oridonin and lupulone are individually effective for the treatment of gastrointestinal disorders (stomachache). See ‘016, page 1 (oridonin) and Matsui, page 10 (lupulone). Accordingly, we find that the evidence of record establishes that a person of ordinary skill in the art would have been motivated to combine oridonin and lupulone into a composition for the treatment of gastrointestinal disorders. See Kerkhoven, Susi, and Crockett. Nevertheless, since the record before us is focused on the combination of the references for the treatment of cancer we will address this issue. Appellant contends that “[t]he cited references do not provide the motivation to combine oridonin and lupulone to treat the same types of cancers, let alone breast and 5 Appellant recognizes that ‘016, ‘434, Son and Ito do not teach the treatment of any particular cancer. Nevertheless, Appellant asserts (Brief, page 9), “[b]ased on the references cited by the Examiner, there appears to be no overlap between the cancer-type specificity of oridonin and lupulone.” What is unclear on this record is how Appellant can reach this conclusion when she recognizes that four of the five references relied upon teach a non-specific anti-cancer activity.Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 Next
Last modified: September 9, 2013